Please use this identifier to cite or link to this item:
http://dx.doi.org/10.25673/110799
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Abu Rumeileh, Samir | - |
dc.contributor.author | Mayer, Benjamin | - |
dc.contributor.author | Still, Veronika | - |
dc.contributor.author | Tumani, Hayrettin | - |
dc.contributor.author | Otto, Markus | - |
dc.contributor.author | Şenel, Makbule | - |
dc.date.accessioned | 2023-09-29T07:07:59Z | - |
dc.date.available | 2023-09-29T07:07:59Z | - |
dc.date.issued | 2022 | - |
dc.identifier.uri | https://opendata.uni-halle.de//handle/1981185920/112754 | - |
dc.identifier.uri | http://dx.doi.org/10.25673/110799 | - |
dc.description.abstract | The description of every possible adverse effect or event related to vaccines is mandatory during the ongoing worldwide COVID-19 vaccination program. Although cases of cutaneous varicella zoster virus (VZV) reactivation after COVID-19 vaccination have been increasingly reported in literature and database sets, a description of VZV-induced neurological disease (VZV-ND) is still lacking. In the present study, we retrospectively evaluated patients admitted to our clinic and diagnosed with VZV-ND during the COVID-19 vaccination campaign (January–April 2021) and in the same months in the previous two years. We identified three patients with VZV-ND after COVID-19 vaccination and 19 unvaccinated VZV-ND cases as controls. In the case–control analysis, the two groups showed no difference in clinical features, results of diagnostic investigations, and outcome. Thus, VZV reactivation with neurological involvement might be a possible event triggered by COVID-19 vaccination, but the benefit following COVID-19 vaccination overcomes significantly the potential risk associated with a VZV reactivation. | eng |
dc.language.iso | eng | - |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
dc.subject.ddc | 610 | - |
dc.title | Varicella zoster virus-induced neurological disease after COVID-19 vaccination : a retrospective monocentric study | eng |
dc.type | Article | - |
local.versionType | publishedVersion | - |
local.bibliographicCitation.journaltitle | Journal of neurology | - |
local.bibliographicCitation.volume | 269 | - |
local.bibliographicCitation.pagestart | 1751 | - |
local.bibliographicCitation.pageend | 1757 | - |
local.bibliographicCitation.publishername | Steinkopff | - |
local.bibliographicCitation.publisherplace | [Darmstadt] | - |
local.bibliographicCitation.doi | 10.1007/s00415-021-10849-3 | - |
local.subject.keywords | COVID-19 · SARS-CoV-2 · Varicella · Zoster · Vaccination · Vaccine | - |
local.openaccess | true | - |
dc.identifier.ppn | 1860504744 | - |
cbs.publication.displayform | 2022 | - |
local.bibliographicCitation.year | 2022 | - |
cbs.sru.importDate | 2023-09-29T07:07:33Z | - |
local.bibliographicCitation | Enthalten in Journal of neurology - [Darmstadt] : Steinkopff, 1891 | - |
local.accessrights.dnb | free | - |
Appears in Collections: | Open Access Publikationen der MLU |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
s00415-021-10849-3.pdf | 489.82 kB | Adobe PDF | ![]() View/Open |